menu
    • menu

    Company profile for RoslinCT

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    RoslinCT is a prominent global Contract Development and Manufacturing Services Organization (CDMO) specializing in Advanced Cell and Gene Therapies. The company holds a distinguished position as one of the early pioneers globally to produce clinical-grade human pluripotent stem cells, emphasizing a robust commitment to science and innovation. In collaboration with its partners, RoslinCT has played a pivotal role in the develop...
    RoslinCT is a prominent global Contract Development and Manufacturing Services Organization (CDMO) specializing in Advanced Cell and Gene Therapies. The company holds a distinguished position as one of the early pioneers globally to produce clinical-grade human pluripotent stem cells, emphasizing a robust commitment to science and innovation. In collaboration with its partners, RoslinCT has played a pivotal role in the development, spanning from early process development to commercialization, of the world's First CRISPR-Edited Cell Therapy Product for a significant inherited disorder with high volume.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RoslinCTunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Edinburgh BioQuarter 9 Little France Road Edinburgh, EH16 4UX Scotland
    Telephone
    Telephone
    +44 01316585180
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.roslinct.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/roslin-cell-therapies-ltd/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/RoslinCT?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BOOST Pharma And RoslinCT Partner To Advance Osteogenesis
    BOOST Pharma And RoslinCT Partner To Advance Osteogenesis

    07 Jan 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-01-07/roslinct-and-boost-pharma-announce-strategic-manufacturing-agreement-to-advance-cell-therapy-for-inf

    PHARMIWEB
    07 Jan 2026
    Share Share
    Roslinct, Ayrmid Expand Partnership To Produce Omisirge
    Roslinct, Ayrmid Expand Partnership To Produce Omisirge

    16 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251216305612/en/RoslinCT-and-Ayrmid-Ltd.-Announce-Expansion-of-Strategic-Partnership-to-Manufacture-Omisirge-omidubicel-onlv-for-Second-FDA-Approved-Indication-in-Severe-Aplastic-Anemia-SAA

    BUSINESSWIRE
    16 Dec 2025
    Share Share
    RoslinCT and Ayrmid Pharma to Partner on Omisirge® Production
    RoslinCT and Ayrmid Pharma to Partner on Omisirge® Production

    11 Mar 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250311357942/en

    BUSINESSWIRE
    11 Mar 2025
    Share Share
    RoslinCT Appoints Professor Sir Peter Mathieson & Alexander New Non-Exec Dir
    RoslinCT Appoints Professor Sir Peter Mathieson & Alexander New Non-Exec Dir

    25 Jun 2024

    // PRESS RELEASE

    https://www.roslinct.com/insights/sir-peter-mathieson-and-alexander-vos-new-non-executive-directors/?_gl=1*welgr*_up*MQ..*_ga*MTY2MjU0MTgxLjE3MTkzMTk4OTU.*_ga_K60EC3HYJY*MTcxOTMxOTg5NC4xLjEuMTcxOTMxOTkwMC4wLjAuMA..

    PRESS RELEASE
    25 Jun 2024
    Share Share
    RoslinCT appoints Professor Sir Peter Mathieson as new non-executive directors.
    RoslinCT appoints Professor Sir Peter Mathieson as new non-executive directors.

    24 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240625300790/en

    BUSINESSWIRE
    24 Jun 2024
    Share Share
    Governor Healey Highlights Life Sciences Investments From Mass Leads Act
    Governor Healey Highlights Life Sciences Investments From Mass Leads Act

    07 Mar 2024

    // PRESS RELEASE

    https://www.roslinct.com/insights/governor-healey-highlights-life-sciences-investments-from-mass-leads-act-in-worcester-and-hopkinton/?_gl=1*1l14zha*_up*MQ..*_ga*MTQzNzg2NzIxMi4xNzEwNzYzNzE5*_ga_K60EC3HYJY*MTcxMDc2MzcxOC4xLjEuMTcxMDc2MzcyMS4wLjAuMA..

    PRESS RELEASE
    07 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search